T32 Urologic Oncology Research Training Program

项目摘要/摘要 自1999年成立以来，T32泌尿外科肿瘤研究培训的主要目标是 纪念斯隆·凯特琳癌症中心(MSK)的计划一直在培训精选的泌尿科医生 从事泌尿外科肿瘤学翻译研究的富有成效的职业。专职的泌尿外科研究培训 肿瘤学对于国家癌症研究所(NCI)降低发病率和 泌尿生殖系癌症的死亡率，占美国所有癌症相关死亡人数的10% 预计随着人口老龄化，发病率将稳步上升。对于建议的 在资助期内，我们寻求继续我们的互动、多学科研究培训战略 整合以下内容：(1)基础、临床和翻译研究人员的多学科学院 横跨外科、医学、癌症生物学和治疗学、分子病理学和 遗传学、免疫疗法、分子放射学、生物统计学和流行病学以及实验室医学， (2)为T32学员的研究兴趣和目标量身定做的强化指导研究实践； (3)设立必修的授课和讨论式课程的核心课程，以提高课程质素 实际操作研究培训，(4)有组织的赠款编写和职业发展讲习班 发展奖，以及(5)让T32学员进一步沉浸其中的选修活动 在癌症研究领域，并与同行和知名领导者建立网络。每年，两个高度 来自密歇根大学泌尿外科肿瘤学奖学金项目的博士后实习生将被选为 T32泌尿系统肿瘤研究培训计划。他们必须有医学博士学位，必须完成 接受过泌尿外科住院医师培训，并且必须是具有董事会资格的泌尿外科医生。这两名学员由 此T32培训助学金为期两年，致力于泌尿外科肿瘤学研究培训，有预约 至第二年，视进展情况而定。在完成培训后，T32的毕业生 泌尿外科肿瘤学研究培训项目有望成为初级教职员工的热门人选 在以研究为重点的学术组织中的任命。在过去10年中，90%的T32学员 毕业生已被录取到学术机构的教职并从事实验室工作 和/或旨在了解和克服泌尿生殖道癌的临床研究。

PROJECT SUMMARY/ABSTRACT Since its inception in 1999, the primary objective of the T32 Urologic Oncology Research Training Program at Memorial Sloan Kettering Cancer Center (MSK) has been to train select urologists for productive careers in translational research in urologic oncology. Dedicated research training in urologic oncology is essential to the mission of the National Cancer Institute (NCI) to reduce morbidity and mortality from genitourinary cancers, which cause about 10% of all cancer-related deaths in the United States and which are expected to rise steadily in incidence as the population ages. For the proposed funding period, we seek to continue our interactive, multidisciplinary research training strategy that integrates the following: (1) a multidisciplinary faculty of basic, clinical, and translational researchers spanning the disciplines of surgery, medicine, cancer biology and therapeutics, molecular pathology and genetics, immunotherapy, molecular radiology, biostatistics and epidemiology, and laboratory medicine, (2) an intensive mentored research practicum tailored to the T32 trainee’s research interests and goals, (3) a core curriculum of required didactic and discussion-based courses to enhance the quality of the hands-on research training, (4) structured career development workshops in grant writing and career development awards, and (5) elective activities that will allow T32 trainees to further immerse themselves in the world of cancer research and to network with peers and established leaders. Each year, 2 highly committed postdoctoral trainees from the Urologic Oncology Fellowship Program at MSK are selected for the T32 Urologic Oncology Research Training Program. They must have an MD, must have completed residency training in urology, and must be board-eligible urologists. These 2 trainees are supported by this T32 training grant during 2 years dedicated to urologic oncology research training, with appointment to the 2nd year contingent on suitable progress. At the completion of their training, graduates of theT32 Urologic Oncology Research Training Program are expected to be attractive candidates for junior faculty appointments at research-focused academic organizations. In the past 10 years, 90% of T32 trainee graduates have matriculated to faculty positions at academic institutions and are engaged in laboratory and/or clinical research aimed at understanding and overcoming genitourinary cancers.